Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0007095,
umls-concept:C0020885,
umls-concept:C0036525,
umls-concept:C0038581,
umls-concept:C0043047,
umls-concept:C0068595,
umls-concept:C0204727,
umls-concept:C0205409,
umls-concept:C1522484,
umls-concept:C1555707,
umls-concept:C1705851,
umls-concept:C1880022,
umls-concept:C1882074,
umls-concept:C2752151,
umls-concept:C2825492,
umls-concept:C2828366
|
pubmed:issue |
3
|
pubmed:dateCreated |
1987-9-17
|
pubmed:abstractText |
A metastasis to the right liver lobe of an argyrophil/argentaffin midgut carcinoid tumour in a patient with the classical carcinoid syndrome was examined for the presence of tachykinins other than substance P, using a specific antiserum. The extract was initially purified using SepPak cartridges, and subsequently subjected to cation-exchange chromatography on SP Sephadex C-25 which separated the immunoreactive material into two main components (components I and II). Both were further purified by anion-exchange chromatography on DEAE-Sephadex A-25, and by reverse-phase fast protein liquid chromatography. Component II was identified as neurokinin A by its immunochemical and chromatographic properties and amino acid sequence analysis. Component I consisted of two molecular forms which were identified as neurokinin A(3-10) and neurokinin A(4-10) by amino acid sequence analysis. The tumour tissue contained only small amounts of the eledoisin-like peptide that has earlier been demonstrated in mammalian tissues. Although this component behaved like the nonmammalian peptide eledoisin on reverse-phase HPLC and on reverse-phase ion-pair chromatography, eledoisin-specific antiserum E2 indicated that eledoisin-like peptide is not identical to eledoisin. Neurokinin A in carcinoid tumours has an N-terminal heterogeneity; this multiplicity constitutes a further support for the hypothesis that carcinoid tumours produce a number of tachykinins which may be present in different relative amounts in individual patients and may contribute to the individual differences in symptomatology.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
0014-2956
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
3
|
pubmed:volume |
166
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
693-7
|
pubmed:dateRevised |
2007-7-23
|
pubmed:meshHeading |
pubmed-meshheading:3038549-Carcinoid Tumor,
pubmed-meshheading:3038549-Chromatography, High Pressure Liquid,
pubmed-meshheading:3038549-Chromatography, Ion Exchange,
pubmed-meshheading:3038549-Humans,
pubmed-meshheading:3038549-Ileal Neoplasms,
pubmed-meshheading:3038549-Liver Neoplasms,
pubmed-meshheading:3038549-Neurokinin A,
pubmed-meshheading:3038549-Neuropeptides,
pubmed-meshheading:3038549-Peptide Fragments,
pubmed-meshheading:3038549-Radioimmunoassay,
pubmed-meshheading:3038549-Solubility,
pubmed-meshheading:3038549-Water
|
pubmed:year |
1987
|
pubmed:articleTitle |
Isolation and characterization of neurokinin A, neurokinin A(3-10) and neurokinin A(4-10) from a neutral water extract of a metastatic ileal carcinoid tumour.
|
pubmed:publicationType |
Journal Article
|